AGO2 and melanoma: Next, we did immunoprecipitation experiments using an antibody against AGO2, an essential component of RISC, in keratinocytes, which express miR-944, and in WM-266-4 melanoma cells, which do not express miR-944, and subsequently performed RT-qPCR.